Literature DB >> 15527698

Defects in the disposal of dying cells lead to autoimmunity.

Udo S Gaipl1, Sandra Franz, Reinhard E Voll, Ahmed Sheriff, Joachim R Kalden, Martin Herrmann.   

Abstract

The fast and efficient uptake of dying cells is of main importance to prevent contact of the immune system with intracellular autoantigens. Insufficient clearance of the latter is discussed to drive the humoral autoimmune response in systemic lupus erythematosus. Many adaptor molecules and receptors are involved in the recognition of dying cells. In this paper we focus on the involvement of phosphatidylserine, glycoproteins, and complement and DNaseI in the clearance of apoptotic and necrotic cells, respectively. Furthermore, extracellular danger signals released from necrotic cells are discussed and the uptake process of primary necrotic cells is investigated in detail. Last but not least, the character and origin of clearance defects observed in some systemic lupus erythematosus patients is presented.

Entities:  

Mesh:

Year:  2004        PMID: 15527698     DOI: 10.1007/s11926-004-0016-1

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  83 in total

Review 1.  Collectins: players of the innate immune system.

Authors:  J Koenraad van de Wetering; Lambert M G van Golde; Joseph J Batenburg
Journal:  Eur J Biochem       Date:  2004-04

Review 2.  Antinuclear autoantibodies: probes for defining proteolytic events associated with apoptosis.

Authors:  C A Casiano; E M Tan
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

Review 3.  Nucleotide receptors: an emerging family of regulatory molecules in blood cells.

Authors:  F Di Virgilio; P Chiozzi; D Ferrari; S Falzoni; J M Sanz; A Morelli; M Torboli; G Bolognesi; O R Baricordi
Journal:  Blood       Date:  2001-02-01       Impact factor: 22.113

4.  Apoptotic cell clearance in systemic lupus erythematosus. I. Opsonization by antiphospholipid antibodies.

Authors:  A A Manfredi; P Rovere; G Galati; S Heltai; E Bozzolo; L Soldini; J Davoust; G Balestrieri; A Tincani; M G Sabbadini
Journal:  Arthritis Rheum       Date:  1998-02

5.  High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus.

Authors:  A Perniok; F Wedekind; M Herrmann; C Specker; M Schneider
Journal:  Lupus       Date:  1998       Impact factor: 2.911

6.  Phagocytosis and clearance of apoptotic cells is mediated by MER.

Authors:  R S Scott; E J McMahon; S M Pop; E A Reap; R Caricchio; P L Cohen; H S Earp; G K Matsushima
Journal:  Nature       Date:  2001-05-10       Impact factor: 49.962

Review 7.  The interaction of C-reactive protein and serum amyloid P component with nuclear antigens.

Authors:  T W Du Clos
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

8.  Extracellular adenosine triphosphate. A shock to hemopoietic cells.

Authors:  P J Nijweide; W E Modderman; C E Hagenaars
Journal:  Clin Orthop Relat Res       Date:  1995-04       Impact factor: 4.176

9.  Lectin binding characteristics of squamous cell carcinomas of the head and neck.

Authors:  A K Lalwani; T E Carey; I J Goldstein; B P Peters
Journal:  Acta Otolaryngol       Date:  1996-01       Impact factor: 1.494

10.  Quantitation and characterization of plasma DNA in normals and patients with systemic lupus erythematosus.

Authors:  L Raptis; H A Menard
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

View more
  14 in total

Review 1.  Immunoregulation of dendritic cells.

Authors:  Mark A Wallet; Pradip Sen; Roland Tisch
Journal:  Clin Med Res       Date:  2005-08

Review 2.  Apoptosis and autoimmunity: when apoptotic cells break their silence.

Authors:  Sandra Franz; Udo S Gaipl; Luis E Munoz; Ahmed Sheriff; Alexandra Beer; Joachim R Kalden; Martin Herrmann
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

3.  A novel role for c-Src and STAT3 in apoptotic cell-mediated MerTK-dependent immunoregulation of dendritic cells.

Authors:  Zuoan Yi; Li Li; Glenn K Matsushima; H Shelton Earp; Bo Wang; Roland Tisch
Journal:  Blood       Date:  2009-08-10       Impact factor: 22.113

Review 4.  Programmed cell removal: a new obstacle in the road to developing cancer.

Authors:  Mark P Chao; Ravindra Majeti; Irving L Weissman
Journal:  Nat Rev Cancer       Date:  2011-12-08       Impact factor: 60.716

5.  CCAAT/enhancer binding protein delta (CEBPD) elevating PTX3 expression inhibits macrophage-mediated phagocytosis of dying neuron cells.

Authors:  Chiung-Yuan Ko; Ling-Hua Chang; Yi-Chao Lee; Esta Sterneck; Chun-Pei Cheng; Shun-Hua Chen; A-Mei Huang; Joseph T Tseng; Ju-Ming Wang
Journal:  Neurobiol Aging       Date:  2010-11-26       Impact factor: 4.673

Review 6.  Clearance of apoptotic cells: implications in health and disease.

Authors:  Michael R Elliott; Kodi S Ravichandran
Journal:  J Cell Biol       Date:  2010-06-28       Impact factor: 10.539

Review 7.  The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs).

Authors:  Gerwyn Morris; Michael Berk; Piotr Galecki; Michael Maes
Journal:  Mol Neurobiol       Date:  2013-09-26       Impact factor: 5.590

8.  Interruption of dendritic cell-mediated TIM-4 signaling induces regulatory T cells and promotes skin allograft survival.

Authors:  Melissa Y Yeung; Martina M McGrath; Masafumi Nakayama; Tetsunosuke Shimizu; Olaf Boenisch; Ciara N Magee; Rozita Abdoli; Hisaya Akiba; Takuya Ueno; Laurence A Turka; Nader Najafian
Journal:  J Immunol       Date:  2013-09-13       Impact factor: 5.422

9.  Progression of murine lupus nephritis is linked to acquired renal Dnase1 deficiency and not to up-regulated apoptosis.

Authors:  Natalya Seredkina; Svetlana N Zykova; Ole P Rekvig
Journal:  Am J Pathol       Date:  2009-06-15       Impact factor: 4.307

10.  Comparison of the kinetics of maturation of phagosomes containing apoptotic cells and IgG-opsonized particles.

Authors:  Michelle S Viegas; Luís M B B Estronca; Otília V Vieira
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.